These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Quest for the best candidate: how much imaging do we need before prescribing cardiac resynchronization therapy? Breithardt OA; Breithardt G Circulation; 2006 Feb; 113(7):926-8. PubMed ID: 16490834 [No Abstract] [Full Text] [Related]
63. Device therapy for remodeling in congestive heart failure. Carraway EA; Rayburn BK Curr Heart Fail Rep; 2007 Mar; 4(1):53-8. PubMed ID: 17386187 [TBL] [Abstract][Full Text] [Related]
64. The QRS narrowing index for easy and early identification of responder to cardiac resynchronization therapy. Coppola G; Bonaccorso P; Corrado E; Ciaramitaro G; Ajello L; Nugara C; Assennato P Int J Cardiol; 2014 Jan; 170(3):440-1. PubMed ID: 24342404 [No Abstract] [Full Text] [Related]
65. Cardiac resynchronization therapy in the intensive care setting; the promise and peril of using implantable devices off label. Braunschweig F; Hauptman PJ Eur J Heart Fail; 2008 Mar; 10(3):220-1. PubMed ID: 18313358 [No Abstract] [Full Text] [Related]
67. eComment: Biventricular pacing improves cardiac function compared to univenticular pacing alone in postoperative patients. Koniari I Interact Cardiovasc Thorac Surg; 2009 Jun; 8(6):678-9. PubMed ID: 19443498 [No Abstract] [Full Text] [Related]
68. The class I-cardiac resynchronization therapy effect? Leon AR J Am Coll Cardiol; 2007 Sep; 50(13):1252-3. PubMed ID: 17888842 [No Abstract] [Full Text] [Related]
69. Long-term effect of cardiac resynchronization therapy on functional mitral valve regurgitation. Sitges M; Vidal B; Delgado V; Mont L; Garcia-Alvarez A; Tolosana JM; Castel A; Berruezo A; Azqueta M; Pare C; Brugada J Am J Cardiol; 2009 Aug; 104(3):383-8. PubMed ID: 19616672 [TBL] [Abstract][Full Text] [Related]
70. Individualizing decisions for patients with prophylactic implantable cardiac defibrillators subject to device advisories: a commentary. Bigger JT; Kleiger RE Am J Cardiol; 2006 Nov; 98(9):1291-3. PubMed ID: 17056349 [No Abstract] [Full Text] [Related]
71. [Optimization of haemodynamics in the device-therapy]. Lemke B; Wiegand UK Herzschrittmacherther Elektrophysiol; 2008 Mar; 19(1):1-2. PubMed ID: 18330669 [No Abstract] [Full Text] [Related]
72. Patients with heart failure who require an implantable defibrillator should have cardiac resynchronisation routinely. Cleland JG; Tageldien A; Maarouf N; Hobson N Heart; 2008 Aug; 94(8):963-6. PubMed ID: 18625785 [No Abstract] [Full Text] [Related]
74. New heart failure therapy: the shape of things to come? Burkhoff D J Thorac Cardiovasc Surg; 2001 Sep; 122(3):421-3. PubMed ID: 11547288 [No Abstract] [Full Text] [Related]
75. Cardiac resynchronization therapy--who benefits? Separating myths from facts. Deshpande S; Tol S; Lokhandwala Y Indian Heart J; 2007; 59(1 Suppl A):A57-62. PubMed ID: 19104133 [No Abstract] [Full Text] [Related]
76. Leading edge: Cardiac pacing site optimization. Estrada A Compend Contin Educ Vet; 2011 Dec; 33(12):E2. PubMed ID: 22180133 [No Abstract] [Full Text] [Related]
77. [Role of cardiac resynchronization therapy for treatment of heart failure]. Berney Lamielle M; Burri H Rev Med Suisse; 2009 Mar; 5(193):504, 506-8. PubMed ID: 19374046 [TBL] [Abstract][Full Text] [Related]
78. Predicting benefit from CRT when is it too little, too late? Exner DV JACC Cardiovasc Imaging; 2011 Oct; 4(10):1077-9. PubMed ID: 21999866 [No Abstract] [Full Text] [Related]
79. Can we predict the non-response to cardiac resynchronization therapy? Donal E; Brunet A; Galli E Acta Cardiol; 2014 Aug; 69(4):366-8. PubMed ID: 25181910 [No Abstract] [Full Text] [Related]
80. Highlighting the R in CRT. Kass DA Circulation; 2007 Sep; 116(13):1434-6. PubMed ID: 17893284 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]